Skip to search formSkip to main contentSkip to account menu

Adenosine A2A Receptor Antagonist PBF-509

Known as: A2AR Antagonist PBF-509, PBF-509 
An orally bioavailable adenosine A2A receptor (A2AR) antagonist, with potential antineoplastic activity. Upon administration, A2AR antagonist PBF-509… 
National Institutes of Health

Search for papers about Adenosine A2A Receptor Antagonist PBF-509

Search papers